Skip to content
PoliticalRepoPoliticalRepo

Subjects · United States

Healthcare

Records whose title is actually about this topic. Use a country filter if the list is still too broad.

151 records in US in 2025

Records

Bill· SS. 3385 (119th)open

Lower Health Care Costs Act

United States · United States Congress · 8 December 2025

Lower Health Care Costs Act This bill extends for three years, through 2028, temporary changes enacted by the American Rescue Plan Act of 2021 (ARPA) and the Inflation Reduction Act of 2022 (IRA) that generally expand eligibility for and increase the amount of the premium tax credit.  Currently, eligible taxpayers may be able to claim the premium tax credit, which applies toward the cost of obtaining health insurance through health insurance exchanges. To be eligible for the premium tax credit, a taxpayer’s household income must meet or exceed 100% of the federal poverty level (FPL) and, after 2025, may not exceed 400% of the FPL (maximum income limit). For 2021-2025, the ARPA and IRA eliminated the maximum income limit, which generally expands eligibility for the premium tax credit. Further, under current law, the amount of the premium tax credit is (1) generally the plan premium (conditions apply), minus (2) the taxpayer’s household income multiplied by the applicable percentage. The applicable percentage is a specific percentage that varies depending on which of six income ranges (adjusted for inflation after 2025) the taxpayer’s household income falls within. For 2021-2025, the ARPA and IRA lowered the applicable percentages and eliminated the adjustment of the applicable percentages for inflation, which generally increases the amount of the premium tax credit. The bill extends for three years, through 2028, the elimination of the 400% maximum income limit, the lower applicable percentages, and the elimination of the inflation adjustment for the applicable percentages.

Bill· SS. 3386 (119th)open

Health Care Freedom for Patients Act of 2025

United States · United States Congress · 8 December 2025

Health Care Freedom for Patients Act of 2025 This bill allows certain individuals with health savings accounts (HSAs) to receive federal payments. It also restricts payments under Medicaid and the Children's Health Insurance Program (CHIP) regarding certain noncitizens and restricts coverage of gender-transition procedures. Specifically, the bill provides funds for the Department of Health and Human Services to deposit payments into an individual’s HSA during 2026-2027 if the individual has a bronze or catastrophic plan through a health insurance exchange, is between the ages of 18 and 64, and has income up to 700% of the federal poverty level (FPL). Individuals may receive $1,000 or $1,500 annually, depending on age.  The bill also provides funds, beginning in 2027, for cost-sharing reductions for certain individuals who have a silver plan and income up to 250% of the FPL. Beginning in 2027, the bill allows any individual to enroll in a catastrophic plan. Currently, these plans are limited to those under the age of 30 or who have certain exemptions. The bill also reduces the enhanced federal matching rate for the Medicaid expansion population in states that provide any health benefits for individuals who are not qualified aliens under federal law. The bill makes Medicaid and CHIP coverage of individuals while their status is being verified optional and conditions federal payment during this period on verification.  Finally, the bill prohibits exchange plans from covering gender-transition procedures as an essential health benefit and prohibits federal payment under Medicaid and CHIP for these procedures.

Bill· HRH.R. 6485 (119th)referred

Skinny Labels, Big Savings Act

United States · United States Congress · 5 December 2025

Skinny Labels, Big Savings Act This bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs. Under current law, the Food and Drug Administration (FDA) may approve generic and biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc. , a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics. The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act: submitting or seeking approval of a skinny label for a generic or biosimilar drug; promoting or commercially marketing a drug with skinny labeling approved by the FDA; or describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug. The bill also applies the safe harbor to similar actions under the Public Health Service Act.

Bill· HRH.R. 6494 (119th)referred

Territories Health Equity Act of 2025

United States · United States Congress · 5 December 2025

Territories Health Equity Act of 2025 This bill alters provisions relating to the treatment of U.S. territories under Medicaid, Medicare, and Medicare Advantage. For example, the bill eliminates Medicaid funding limitations for U.S. territories beginning in FY2026, exempts an individual from late-enrollment penalties for Medicare medical services if the individual resided in Puerto Rico as of the date of eligibility and the individual enrolls within five years of such date, and establishes minimum criteria for certain elements used in Medicare Advantage payment calculations for areas within U.S. territories. The bill also allows residents of U.S. territories who are unable to obtain health insurance through their employer or a health insurance exchange to instead obtain coverage that is at least as broad as the coverage available to Members of Congress and their staff through the District of Columbia exchange.

Bill· SS. 3350 (119th)referred

ACO Assignment Improvement Act of 2025

United States · United States Congress · 4 December 2025

ACO Assignment Improvement Act of 2025 This bill establishes additional requirements for assigning Medicare fee-for-service beneficiaries to accountable care organizations (ACOs) under the Medicare shared savings program. Under current law, the program enables ACOs to receive payments for savings stemming from care coordination and management. The bill requires the basis for assignment to reflect beneficiaries' utilization of not only primary care services provided by ACO physicians, but also those provided by other ACO practitioners—specifically, physician assistants, nurse practitioners, and clinical nurse specialists.

Bill· SS. 3349 (119th)referred

PBM Disclosure Act

United States · United States Congress · 4 December 2025

Bill· HRH.R. 6420 (119th)referred

ACCESS Act

United States · United States Congress · 4 December 2025

Bill· HRH.R. 6421 (119th)referred

IMPACT Act of 2025

United States · United States Congress · 4 December 2025

Bill· HRH.R. 6423 (119th)referred

HELP Copays Act

United States · United States Congress · 4 December 2025

Bill· HRH.R. 6396 (119th)referred

Kid PROOF Act of 2025

United States · United States Congress · 3 December 2025

Bill· HRH.R. 6408 (119th)referred

ANCHOR Act of 2025

United States · United States Congress · 3 December 2025

Bill· HRH.R. 6407 (119th)referred

RCORP Authorization Act

United States · United States Congress · 3 December 2025

Bill· HRH.R. 6393 (119th)referred

DSH in Tennessee Act

United States · United States Congress · 3 December 2025

Bill· SS. 3302 (119th)referred

Mikaela Naylon Give Kids a Chance Act of 2025

United States · United States Congress · 2 December 2025

Mikaela Naylon Give Kids a Chance Act of 2025 This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer, and renews the Food and Drug Administration’s (FDA’s) authority to award priority review vouchers (PRVs) to sponsors of new products for rare pediatric diseases. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs used in combination with active ingredients that have already been approved and that (1) have been determined to be part of the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer. The FDA must issue guidance on the implementation of these provisions and report to Congress on its efforts to ensure implementation. The Government Accountability Office (GAO) must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs. The bill also renews the FDA’s authority to issue PRVs to sponsors of new products intended to treat rare pediatric diseases through September 30, 2030. This is known as the Rare Pediatric Disease PRV program. The program expired in December 2024. GAO must report on the effectiveness of the Rare Pediatric Disease PRV program, including to what extent PRVs were successful in promoting drug development and expediting patient access to drugs for the treatment or prevention of rare pediatric diseases.

Bill· SS. 3304 (119th)referred

Medical Foods and Formulas Access Act of 2025

United States · United States Congress · 2 December 2025

Medical Foods and Formulas Access Act of 2025 This bill expands coverage under Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Federal Employees Health Benefits Program to include medically necessary food and associated equipment and supplies. The bill defines medically necessary food as specially formulated and processed products (e.g., nutritional formulas) prescribed by health care practitioners for individuals who have special dietary requirements because of certain digestive or metabolic disorders or conditions.

Bill· SS. 3315 (119th)open

Health Care Cybersecurity and Resiliency Act of 2026

United States · United States Congress · 2 December 2025

Health Care Cybersecurity and Resiliency Act of 2026 This bill expands federal requirements and resources for preventing and responding to cybersecurity incidents in the health care and public health sectors. The bill directs the Department of Health and Human Services (HHS) to require private health care-related entities to adopt minimum cybersecurity practices (e.g., multifactor authentication), more specifically identify the standards for mitigating penalties relating to violations of health information privacy and security, expand and update biennially a specified plan that details cybersecurity protocols for HHS personnel, provide training and best practices to support the expansion of the workforce for health care cybersecurity,  provide guidance on cybersecurity readiness to rural entities, and designate one representative to lead oversight and coordination of cybersecurity activities within HHS. Also, HHS and the Cybersecurity and Infrastructure Security Agency (CISA) must coordinate to improve health care cybersecurity, including by (1) providing resources for entities receiving information from HHS or CISA programs, and (2) establishing a joint cybersecurity capability plan to coordinate responses to significant incidents. Additionally, the bill requires health care providers and plans to include the number of individuals affected when notifying individuals of unauthorized access to health information (i.e., a breach). 

Bill· SS. 3299 (119th)referred

DSH in Tennessee Act

United States · United States Congress · 2 December 2025

Bill· SS. 3300 (119th)referred

ANCHOR Act of 2025

United States · United States Congress · 2 December 2025

Bill· HRH.R. 6364 (119th)referred

Kidd’s Stuttering Act

United States · United States Congress · 2 December 2025

PreviousPage 3 of 4Next